|
Volumn 303, Issue 5665, 2004, Pages 1754-1755
|
Gene Expression Tests Foretell Breast Cancer's Future
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ONCOLOGY;
PATIENT TREATMENT;
TUMORS;
BREAST CANCER;
GENE EXPRESSION;
GENES;
ANTINEOPLASTIC AGENT;
ESTROGEN RECEPTOR;
TAMOXIFEN;
TRASTUZUMAB;
CANCER;
MEDICINE;
BREAST CANCER;
CLINICAL TRIAL;
GENE;
GENE EXPRESSION;
GENOME;
HEART FAILURE;
HUMAN;
INFECTION;
LEUKEMIA;
METASTASIS;
PRIORITY JOURNAL;
SHORT SURVEY;
ARTICLE;
BREAST TUMOR;
DNA MICROARRAY;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
GENE EXPRESSION PROFILING;
GENETICS;
GENOMICS;
PATHOLOGY;
PREDICTION AND FORECASTING;
PROGNOSIS;
REPRODUCIBILITY;
RISK FACTOR;
STANDARD;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
FEMALE;
GENE EXPRESSION PROFILING;
GENOME, HUMAN;
GENOMICS;
HUMANS;
NEOPLASM METASTASIS;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
REPRODUCIBILITY OF RESULTS;
RISK FACTORS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 1642349616
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.303.5665.1754 Document Type: Short Survey |
Times cited : (49)
|
References (0)
|